Duke Clinical Research Institute, Duke University, Durham, NC 27715, USA.
N Engl J Med. 2010 Mar 11;362(10):886-95. doi: 10.1056/NEJMoa0907272.
Guidelines for triaging patients for cardiac catheterization recommend a risk assessment and noninvasive testing. We determined patterns of noninvasive testing and the diagnostic yield of catheterization among patients with suspected coronary artery disease in a contemporary national sample.
From January 2004 through April 2008, at 663 hospitals in the American College of Cardiology National Cardiovascular Data Registry, we identified patients without known coronary artery disease who were undergoing elective catheterization. The patients' demographic characteristics, risk factors, and symptoms and the results of noninvasive testing were correlated with the presence of obstructive coronary artery disease, which was defined as stenosis of 50% or more of the diameter of the left main coronary artery or stenosis of 70% or more of the diameter of a major epicardial vessel.
A total of 398,978 patients were included in the study. The median age was 61 years; 52.7% of the patients were men, 26.0% had diabetes, and 69.6% had hypertension. Noninvasive testing was performed in 83.9% of the patients. At catheterization, 149,739 patients (37.6%) had obstructive coronary artery disease. No coronary artery disease (defined as <20% stenosis in all vessels) was reported in 39.2% of the patients. Independent predictors of obstructive coronary artery disease included male sex (odds ratio, 2.70; 95% confidence interval [CI], 2.64 to 2.76), older age (odds ratio per 5-year increment, 1.29; 95% CI, 1.28 to 1.30), presence of insulin-dependent diabetes (odds ratio, 2.14; 95% CI, 2.07 to 2.21), and presence of dyslipidemia (odds ratio, 1.62; 95% CI, 1.57 to 1.67). Patients with a positive result on a noninvasive test were moderately more likely to have obstructive coronary artery disease than those who did not undergo any testing (41.0% vs. 35.0%; P<0.001; adjusted odds ratio, 1.28; 95% CI, 1.19 to 1.37).
In this study, slightly more than one third of patients without known disease who underwent elective cardiac catheterization had obstructive coronary artery disease. Better strategies for risk stratification are needed to inform decisions and to increase the diagnostic yield of cardiac catheterization in routine clinical practice.
为了对行心导管检查的患者进行分诊,指南推荐进行风险评估和非侵入性检查。我们在一个当代全国性样本中确定了疑似冠心病患者的非侵入性检查模式和心导管检查的诊断收益。
2004 年 1 月至 2008 年 4 月,在美国心脏病学会国家心血管数据注册中心的 663 家医院中,我们确定了正在接受选择性心导管检查的无已知冠心病患者。将患者的人口统计学特征、危险因素和症状以及非侵入性检查的结果与阻塞性冠状动脉疾病相关联,阻塞性冠状动脉疾病定义为左主干冠状动脉直径狭窄 50%或以上或主要心外膜血管直径狭窄 70%或以上。
共有 398978 例患者纳入研究。中位年龄为 61 岁;52.7%的患者为男性,26.0%患有糖尿病,69.6%患有高血压。83.9%的患者进行了非侵入性检查。在导管检查中,149739 例患者(37.6%)存在阻塞性冠状动脉疾病。39.2%的患者报告无冠状动脉疾病(定义为所有血管狭窄<20%)。阻塞性冠状动脉疾病的独立预测因素包括男性(优势比,2.70;95%置信区间[CI],2.64 至 2.76)、年龄较大(每 5 年增加 1.29 的优势比[CI],1.28 至 1.30)、存在胰岛素依赖型糖尿病(优势比,2.14;95%CI,2.07 至 2.21)和存在血脂异常(优势比,1.62;95%CI,1.57 至 1.67)。进行非侵入性检查的阳性结果患者比未进行任何检查的患者更有可能患有阻塞性冠状动脉疾病(41.0%比 35.0%;P<0.001;调整后的优势比,1.28;95%CI,1.19 至 1.37)。
在这项研究中,略多于三分之一的接受择期心导管检查的无已知疾病的患者存在阻塞性冠状动脉疾病。需要更好的风险分层策略,以便在常规临床实践中做出决策并提高心导管检查的诊断收益。